Cargando…
Case Report: Bullous Lung Disease Following COVID-19
More than 87% of patients report the persistence of at least one symptom after recovery from the Coronavirus disease 2019 (COVID-19). Dyspnea is one of the most frequently reported symptoms following severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) infection with persistent chest radiolo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635639/ https://www.ncbi.nlm.nih.gov/pubmed/34869488 http://dx.doi.org/10.3389/fmed.2021.770778 |
_version_ | 1784608367235301376 |
---|---|
author | Pednekar, Prachi Amoah, Kwesi Homer, Robert Ryu, Changwan Lutchmansingh, Denyse D. |
author_facet | Pednekar, Prachi Amoah, Kwesi Homer, Robert Ryu, Changwan Lutchmansingh, Denyse D. |
author_sort | Pednekar, Prachi |
collection | PubMed |
description | More than 87% of patients report the persistence of at least one symptom after recovery from the Coronavirus disease 2019 (COVID-19). Dyspnea is one of the most frequently reported symptoms following severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) infection with persistent chest radiological abnormalities up to 3 months after symptom onset. These radiological abnormalities are variable and most commonly include ground-glass opacities, reticulations, mosaic attenuation, parenchymal bands, interlobular septal thickening, bronchiectasis, and fibrotic-like changes. However, in this case report, we describe findings of bullous lung disease as a complication of SARS CoV-2 infection. As the pandemic continues, there is a need to understand the multiple respiratory manifestations of post-acute sequelae of COVID-19. We, therefore, present this case to add to the current body of literature describing pulmonary disease as a consequence of SARS CoV-2 infection. |
format | Online Article Text |
id | pubmed-8635639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86356392021-12-02 Case Report: Bullous Lung Disease Following COVID-19 Pednekar, Prachi Amoah, Kwesi Homer, Robert Ryu, Changwan Lutchmansingh, Denyse D. Front Med (Lausanne) Medicine More than 87% of patients report the persistence of at least one symptom after recovery from the Coronavirus disease 2019 (COVID-19). Dyspnea is one of the most frequently reported symptoms following severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) infection with persistent chest radiological abnormalities up to 3 months after symptom onset. These radiological abnormalities are variable and most commonly include ground-glass opacities, reticulations, mosaic attenuation, parenchymal bands, interlobular septal thickening, bronchiectasis, and fibrotic-like changes. However, in this case report, we describe findings of bullous lung disease as a complication of SARS CoV-2 infection. As the pandemic continues, there is a need to understand the multiple respiratory manifestations of post-acute sequelae of COVID-19. We, therefore, present this case to add to the current body of literature describing pulmonary disease as a consequence of SARS CoV-2 infection. Frontiers Media S.A. 2021-11-17 /pmc/articles/PMC8635639/ /pubmed/34869488 http://dx.doi.org/10.3389/fmed.2021.770778 Text en Copyright © 2021 Pednekar, Amoah, Homer, Ryu and Lutchmansingh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Pednekar, Prachi Amoah, Kwesi Homer, Robert Ryu, Changwan Lutchmansingh, Denyse D. Case Report: Bullous Lung Disease Following COVID-19 |
title | Case Report: Bullous Lung Disease Following COVID-19 |
title_full | Case Report: Bullous Lung Disease Following COVID-19 |
title_fullStr | Case Report: Bullous Lung Disease Following COVID-19 |
title_full_unstemmed | Case Report: Bullous Lung Disease Following COVID-19 |
title_short | Case Report: Bullous Lung Disease Following COVID-19 |
title_sort | case report: bullous lung disease following covid-19 |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635639/ https://www.ncbi.nlm.nih.gov/pubmed/34869488 http://dx.doi.org/10.3389/fmed.2021.770778 |
work_keys_str_mv | AT pednekarprachi casereportbullouslungdiseasefollowingcovid19 AT amoahkwesi casereportbullouslungdiseasefollowingcovid19 AT homerrobert casereportbullouslungdiseasefollowingcovid19 AT ryuchangwan casereportbullouslungdiseasefollowingcovid19 AT lutchmansinghdenysed casereportbullouslungdiseasefollowingcovid19 |